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Abstract.  
Singlet oxygen (1O2), as an important kind of reactive oxygen species (ROS) and main 
therapeutic agent in photodynamic therapy (PDT), only have a half-life of 40 ns and an 
effective radius of 20 nm, which cause significant obstacles for improving PDT efficacy. In 
this work, we developed novel upconversion nanoparticle (UCN)-based nanoplatforms with a 
minimized distance between UCNs and a photosensitizer, protoporphyrin IX (PpIX), and a 
controllable payload of PpIX, to enhance and control ROS production. The ability of the 
nanoplatform to target different subcellular organelles such as cell membrane and 
mitochondria was demonstrated via surface modification of the nanoplatform with different 
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targeting ligands. The results showed that the mitochondria-targeting nanoplatforms resulted 
in significantly increased capability of both tumor cell-killing and inhibition of tumor growth. 
Subcellular targeting of nanoparticles leads to the death of cancer cells in different manners. 
However, the efficiency of ROS generation almost had no influence on the tumor cell 
viability during the period of evaluation. These findings suggest that specific subcellular 
targeting of the nanoplatforms enhances the PDT efficacy more effectively than the increase 
of ROS production, and may shed light on future novel designs of effective and controllable 
PDT nanoplatforms. 
 
1. Introduction 
Photodynamic therapy (PDT) is a tumor-ablative oncologic intervention that involves the 
excitation of photosensitizer (PS) molecules with light of a specific wavelength[1,2] to produce 
cytotoxic reactive oxygen species (ROS) for irreversibly damaging tumor cells[3]. Its merits 
are minimal invasiveness and low side effects. However, the challenges are to ablate tumor 
tissues with high efficiency, including limited penetrating depths, low ROS production 
efficiency, short half-lives and effective radii of singlet oxygen (1O2), the most effective kind 
of ROS[4,5]. As an emerging platform in the field of PDT, upconversion nanoparticles (UCNs) 
serving as a PS carrier have attracted intensive attention in recent years[6,7]. Upon near-
infrared (NIR) light excitation, UCNs are able to emit visible or ultraviolet light with 
controllable wavelengths, which could match the absorption wavelength of the loaded 
photosensitizer, and therefore play as a transducer. Given the deep tissue penetration 
capability of NIR light[8], NIR-excited UCNs can be located in in-depth tissues to activate 
loaded PS molecules for PDT treatment.  
 
In the past decade, various strategies to load PS molecules onto UCNs have been designed for 
improving PDT efficacy, mainly in terms of optimization of ROS production[9-16]. One of the 
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strategies was to improve the match between the wavelength bands of UCN emission and PS 
absorption. For example, Chen et. al.[9] chose methylene blue as the photosensitizer which had 
a mismatch of <5 nm between its absorption wavelength and the emission wavelength of 
UCNs. Idris et. al.[10] simultaneously conjugated a type of UCNs with two different PS 
molecules, in which the absorption peak of each PS molecule matched well with one of the 
major emission peaks of UCNs for efficient energy transfer and absorption. However, these 
optimized methods were still not sufficient to regress tumor cells completely[10]. Other 
strategies were also designed to elevate the loading capacity of the photosensitizer in order to 
increase ROS production. For example, Cui et al.[11] developed amphiphilic chitosan modified 
UCNs with a PS loading capacity of up to ~10%, resulting in inhibiting 66 wt% tumor growth 
as compared to the blank control. However, in these approaches, a coating layer of silica or 
polymer with a thickness generally greater than 10 nm[9-15] was demanded for sufficient PS 
loading.  Owing to the fact that ROS production is an energy transfer process, a thicker layer 
of PS loading, which means the increased distance between PS molecules and UCNs, will 
largely reduce the efficiency of energy transfer. Furthermore, the increased production of 
ROS arising from the increasing concentration of nanocarriers[14,16] may also lead to the risks 
of toxicity. Thus, it is worth developing novel strategies to improve the extent of tumor 
regression via the increase of PDT efficacy.  
 
Because of the short half-life and effective radius of 1O2, the dominant kind of ROS[5,17], the 
effective area to damage tumor cells is limited to the neighborhood of the nanoplatforms in 
subcellular scale. Meanwhile, each therapeutic agent has an optimal mechanism of action, 
which usually occurs primarily in a specific subcellular organelle in order to initiate precise 
inhibition or apoptosis of a cancer cell[18-20]. For example, pro-apoptotic drugs have primary 
effect on mitochondrial membrane[21], and oligonucleotides for gene therapy must home in the 
cytosol and nucleus[22,23]. Previous results from the delivery of classical drugs to specific 
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organelles revealed that the therapeutic efficacy was several-fold greater than that of non-
targeted drugs through modification with liposome[24], dendrimer[25], or polymeric carriers[26-
29]; those non-targeted drugs were uncontrolledly released under the disintegration of 
liposomes or the degradation of polymeric carriers. Therefore, it is reasonable to hypothesize 
that UCN-based PDT nanoplatforms targeting to particular subcellular organelles can 
precisely generate 1O2 within the effective location to kill tumor cells, and can be 
spatiotemporally controllable since the NIR light can trigger 1O2 generation in an immediate 
and sensitive manner[30-32].   
 
Furthermore, direct experimental results concerning the dose effect of ROS on PDT efficacy 
have not been reported in the literature despite that ROS is the therapeutic agent in 
photodynamic therapy. Photosensitizers can continuously produce ROS so long as it is under 
the illumination of an appropriate light with a continuous oxygen supply[30, 32-34], meaning that 
a sufficient amount of ROS can be generated even by a nanocarrier with a low loading of a 
photosensitizer under a prolonged illumination. Yet, it remains unclear whether the amount of 
ROS produced under a relatively long irradiation time is sufficient for efficient PDT therapy.  
 
To address the above issues, we aimed to identify the crucial factors that can improve the 
PDT efficacy effectively by increasing ROS production and targeting ROS production at the 
subcellular position. Nanoplatforms, based on UCN as a light transducer and protoporphyrin 
IX (PpIX) as the ROS producer, with novel features were designed.  To investigate the effect 
of ROS production on PDT efficacy, 1) a thinner PpIX-loaded layer (3~5 nm) outside UCN 
nanoparticles was designed to improve the efficiency of energy transfer between UCN core 
and PpIX molecules; and 2) a controllable payload of PpIX was applied to adjust the 
efficiency of ROS generation. To study the impact of subcellular positioning on PDT efficacy, 
different pertinent targeting ligands were covalently bonded onto the nanoplatform to target 
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different subcellular organelles. The PDT efficacy of novel nanoplatforms were characterized 
through both in vitro and in vivo studies. The effect of irradiation time on the PDT therapy 
was also investigated. 
 
2. Results 
2.1. UCN based PDT nanoplatforms with a 3-5 nm silica coating layer 
Two approaches for loading PpIX in a 3~5 nm silica layer were conducted in this work, 
together with a control method that produced a ~15 nm coating. The thin silica outside 
nanoparticles, as a close UCN-PpIX proximity for energy transfer, was successfully prepared 
by a modified reverse microemulsion approach[16,34], as shown in Figure 1. Notable features 
of the modified method include: firstly, the addition of a small amount of dimethyl sulfoxide 
(DMSO) into the water phase of the emulsion, which increases the solubility of PpIX in the 
water phase and therefore improves its dispersion; secondly, an aminopropyltriethoxysilane 
agent was used as a silica precursor for making the thin coating layer (denoted as sample 
APTS). Meanwhile a novel synthetic method was also designed in which PpIX was first 
covalently conjugated with aminopropyltriethoxysilane (see Supporting information) [35]. The 
conjugation was then used as a coating precursor. The latter method allowed us to adjust the 
loading amount of PpIX and the resultant nanoplatforms were labeled as sample CovX (X = 1, 
1.5, 3, 6, each number indicative of a different amount of PpIX feeding, see Figure 1). We 
also prepared the control samples by coating UCNs with tetraethylorthosilicate as a silica 
precursor (denoted as sample TEOS). TEM images of silica coated UCNs are shown in 
Figure 1. UCNs show monodispersion with a size of ~40 nm in diameter before coating. 
Using aminopropyltriethoxysilane as the precursor successfully limited the thickness of the 
outer coating layer to ~3.0 nm. Similarly, a coating layer by use of silane covalently bonded 
with PpIX has only about 3~5 nm in thickness.  However, coating of a tetraethylorthosilicate-
based layer led to a ~15 nm increase in thickness of the outer layer.  
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2.2. Controlled and increased ROS producing efficacy 
The amount of PpIX incorporated in the coating layer was determined by comparing UV–Vis 
absorption measured at 410 nm to a standard concentration-absorption curve. A blank sample 
of only silica coated UCNs was regarded as a control without any absorption at 410 nm in the 
UV-Vis curve. This indicates that addition of silica has no interference on the UV–Vis 
absorption of UCNs. The results are shown in the table of Figure 1. Under the same amount 
of PpIX added, use of aminopropyltriethoxysilane led to ~1.12% PpIX incorporated in the 
coating layer, lower than the tetraethylorthosilicate of ~1.70%. In contrast, with PpIX pre-
attached to aminopropyltriethoxysilane as precursor, the loading amounts of PpIX 
incorporated in the coating layer vary significantly from ~0.46% (Cov1) to ~3.26% (Cov6). 
Since the feeding doses of PpIX in samples TEOS and APTS are the same as that of Cov6, it 
can be concluded that the PpIX-silane precursor for sample Cov6 results in an enhanced 
loading amount of PS molecules (~3.26%) compared to those of TEOS (~1.70%) and APTS 
(~1.12%). 
 
The influence of coating layer thickness on the steady state energy transfer efficiency between 
UCNs and PpIX was evaluated by measuring the fluorescent intensity of drug-loaded 
UCNs[36]. As shown in the table of Figure 1, all ‘Cov’ samples have the energy transfer 
efficiency in the range of 32~85% with an outer layer of 3~5 nm in thickness. In contrast, 
sample TEOS with a 15 nm-thick outer layer has drastically lower energy transfer efficiency, 
13.6%, despite of a higher amount of PpIX incorporated in the coating layer than Cov1 and 
Cov 1.5. Meanwhile, the transient state energy transfer efficiency was measured by the 
luminescence decay lifetime[36]. The results showed that the decay time of 540 nm emission of 
UCNs coating with a 3-5nm SiO2 was significantly shortened after loading with PpIX, while 
that of 660nm almost kept the same (shown in Figure S3). Accordingly, the energy transfer 
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efficiency was about 42.9%, 41.1%, and 13.6% for the sample Cov3, APTS, and TEOS, 
respectively.  
 
The capability of the nanoplatforms to generate ROS was investigated by using a chemical 
method with 1,3-diphenylisobenzofuran (DPBF) as an acceptor of ROS generated. In this 
assay, the reaction of DPBF with ROS results in the decay of its absorption intensity of DPBF 
in UV-Vis curve. Such a spectral change of DPBF in UV-Vis curve allows us to determine the 
concentration of ROS produced from different UCN hybrid samples[37]. Under 980 nm laser 
irradiation, the absorption intensity of DPBF at about 400 nm decreased gradually with time 
in all samples (as shown in Figure S4), from which time-dependent curves of ROS generation 
can be determined. As shown in Figure 2a, under the same NIR laser excitation, sample Cov6 
possesses the highest ROS generation efficiency, followed by samples Cov3, APTS, Cov1.5, 
consequently, and samples Cov1 and TEOS show the lowest. Obviously, with a coating layer 
of the same thickness of 3~5 nm, the higher the loading amount of PpIX incorporated in the 
coating layer is, the higher the ROS generation efficiency will be. Based on the results of 
samples APTS and Cov3 with almost the same amount of PpIX, the ROS generation 
efficiency is barely influenced by the covalent bonding between PpIX and 
aminopropyltriethoxysilane. However, the ROS generation efficiency of sample Cov3 with 
the thickness of 3~5 nm is much higher than sample TEOS with the coating thickness of ~15 
nm, although the loading of PpIX on Cov3 is slightly less than TEOS. This observation 
clearly suggests that PpIX loading in the thinner coating layer leads to higher ROS generating 
efficiency due to a shorter distance between photosensitizer molecules and UCNs.  
 
As 1O2 is the main executive part with short half-life in ROS, we further determining the 
generation of 1O2 by using 9,10-anthracenediyl-bis(methylene) dimalonic acid (ABMDMA) 
as the indicator, owing to that the absorbance of ABMDMA in visible range can be decayed 
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by 1O2[38,39]. We found that the UV-Vis spectra of samples were gradually quenched with 
prolonging irradiation time, as shown in Figure S5. Meanwhile the dose of produced 1O2 
(Figure 2b) showed a similar regularity with the results of ROS generation. The results 
demonstrated the effective production of 1O2 by the presented nanoplatforms, and the dose of 
1O2 could be varied with controlling the thickness of coating layer and loading amount of PS.  
  
2.3. Subcellular targeting via surface modification 
Due to the availability of the amine group originated from aminopropyltriethoxysilane, a 
NH2/COOH coupling reaction can be used to conjugate certain targeting ligands onto the 
nanoplatforms. In our case, folic acid (FA) [37,40] and (3-carboxypropyl) triphenylphosphonium 
bromide (TPP) [41,42] were conjugated onto the surface of nanoparticles respectively (as shown 
in Figure 3a).  The cellular uptake of surface modified UCNs-PpIX nanoparticles was 
observed using a two-photon fluorescence confocal microscope, which is equipped with a 980 
nm pulse laser resource. Figure 3a shows images of HeLa cells associated with each of these 
UCNs-PpIX nanoparticles in which nuclei are detected by 4',6-diamidino-2-phenylindole 
(DAPI) staining. Each of the UCN-PpIX nanoparticles, stained with DAPI, shows green 
luminescence at the location close to a cell nucleus.  Compared to unmodified UCN-PpIX 
nanoparticles, the modification with FA or TPP significantly increased the cellular uptake 
amount of UCNs. For quantitative analysis, the amounts of UCN-PpIX nanoparticles were 
determined by using inductively coupled plasma-atomic emission spectroscopy (ICP-AES) as 
summarized in Figure 3b. The results showed the surface modification with either FA or TPP 
ligand increased the cellular uptake amount of UCNs-PpIX nanoparticles by up to ~6 times 
higher than unmodified UCNs-PpIX nanoparticles, confirming the cell imaging results. 
Without surface modification, the difference in cellular uptake was ~2.5-fold between APTS 
and Cov6. However, samples APTS and Cov6 with FA or TPP modification have similar 
amounts of cellular uptake. Transmission electron microscopy (TEM) was employed to 
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observe the subcellular locations of the above nanoparticles. Figure 4 shows TEM images of 
HeLa cells incubated with Cov6 samples with different surface modifications. It is clearly 
visible that most of the UCNs-PpIX nanoparticles modified with FA are located near the cell 
membrane. In contrast, the UCNs-PpIX nanoparticles modified with TPP were mainly found 
near mitochondria. 
To further identify mitochondria targeting of TPP modified nanoparticles, Rhodamine 123 
(Rh123) was used to specifically stain the mitochondria of Hela cells internalized with Cov6-
TPP and Cov6-FA, respectively, while a control experiment without nanoparticles was 
performed. The images of control group indicated the successful staining of DAPI and Rh123 
(as shown in Figure 5). For the experimental groups, we directly observed the fluorescence of 
PpIX (λex=552nm, λex=700nm) loaded on UCNs. The results showed that for the sample 
Cov6-FA, the fluorescence from PpIX and Rh123 are almost separated. In contrast, the 
fluorescence from PpIX in sample Cov6-TPP are almost covered by Rh123, indicating a 
efficient delivery to mitochondria. For statistically analysizing the targeting efficiency, a 
Pearson’s correlation coefficient that identify colocalization of the fluorescence from Rh123 
and PpIX was calculated with an imaging analysis software ImageJ, based on about 2000 
cells for each sample. Pearson’s correlation coefficient is one of the standard procedures in 
pattern recognition for matching one image with another and can be used to describe the 
degree of overlap between two patterns.[43] Our result showed that Pearson Coefficient for the 
sample Cov6-TPP is 0.817±0.029, while for the sample Cov6-FA it is 0.567±0.064, which 
indicates that the modification of TPP tailors more nanoparticles to the sites near 
mitochondria.  
2.4. In vitro studies on the influence of ROS generation, irradiation time and 
nanoparticle position 
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To study the influence of nanoparticle position on PDT efficacy, we first evaluated all the 
unmodified samples in a control experiment. Without 980 nm irradiation, HeLa cells 
incubated with all the unmodified samples were alive and their viability generally remained 
almost 100% (Figure 6, blue bars). Upon irradiation for 15 min (Figure 6, pink bars), the 
viability of HeLa cells incubated with all the unmodified samples decreased to the range of 
60–70%, which implies death of some HeLa cells. Although the difference in the cellular 
uptake between unmodified APTS and unmodified Cov6 was ~2.5 times, there was almost no 
significant difference between cell viabilities of both samples. This enlightens that the uptake 
amount of nanoparticles is not the only factor influencing the viability of HeLa cells. 
Furthermore, we performed the same evaluation experiment of cell viability without washing 
after incubation with all the unmodified samples to maintain the same total amounts of 
nanoparticles. Under the same condition of irradiation for 15 min, the average cell viabilities 
for all the unwashed samples were only slightly further decreased (Figure 6, green bars).  
Again, this implies that cell-killing efficacy is more relevant to the subcellular location of 
nanoparticles rather than the total dose. 
 
The effect of the subcellular locations of UCNs-PpIX nanoparticles on the cell viability was 
measured by Cov6 samples with and without ligand modification. As shown in Figure 7, 
without NIR irradiation, there is no apparent decrease in cell viabilities and no difference for 
all samples. After NIR irradiation for 10 min, the cell viability of HeLa cells incubated with 
FA-modified Cov6 (located near cell membrane) is ~15% lower than treated with unmodified 
Cov6 (67%~70%). Furthermore, cell viability of HeLa cells incubated with TPP-modified 
Cov6 (located near mitochondria) significantly decreased to ~40%, much lower than the 
sample FA-modified Cov6. As discussed earlier, the cellular uptake amount of Cov6-TPP is 
only slightly lower than that of Cov6-FA (Figure 3b). Therefore, these results imply that 
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locating UCNs-PpIX nanoparticles at certain subcellular position, such as mitochondria, is 
more effective for improving PDT efficacy.  
Figure 7 also showed that the effect of irradiation time on the cell viability of each Cov6 
sample. The results showed that irradiation within 30 min leads to almost the same viability of 
cells for all samples. However, prolongation of exposure time above 30 min results in a 
further decrease in the viability of HeLa cells for all the three kinds of surface modified 
samples. With the same FA modification shown in Figure 8, the cell viabilities of samples 
APTS, Cov1.5 and Cov6 experienced almost the same decreases during the same periods of 
NIR irradiation. Samples APTS and Cov6 modified with different ligands were also compared 
(Figure 9). The results showed no significant statistical difference between APTS and Cov6 
under the same NIR irradiation time. As shown in Figure 2, the ROS generation of Cov6 is 
about 3-fold higher than samples APTS and Cov1.5. Therefore, the above results indicate that 
there is no direct correlation between the cell viability and the amount of ROS generation. 
 
Fluorescence-activated cell sorting (FACS) technique allows us to investigate the mechanisms 
underlying the cytotoxicity of nanoparticles such as the extent of DNA damage[44]. The FACS 
results for both two Cov6 samples (Figure 10) showed that the number of cells positively 
stained by Annexin V and/or propidium iodine (PI) increased after 15 min irradiation, 
demonstrating the death of cells. When the irradiation time was prolonged to 60 min, 
treatment with FA-modified Cov6 led to the significant increase of cells only positively 
stained by PI, indicating that the membrane integrity of cells was destroyed in this case. In 
contrast, TPP-modified Cov6 sample significantly results in the location of both Annexin V 
and PI double stained, indicating the necrosis and late stage apoptosis of HeLa cells with an 
integrated membrane.  All these experimental results were consistently reproducible. 
 
2.5. In vivo studies on the influence of nanoparticle position 
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The PDT efficacy of nanoparticles with different surface modifications was further 
investigated on tumor-bearing mouse model with n=6 for each group. For the groups with 
injected UCNs-PpIX nanoparticles under irradiation of NIR laser, green light emitted from in 
vivo nanoparticles can be clearly observed by naked eyes (Figure 11a), indicating the 
successful NIR penetration through living body for its potential in simultaneous NIR 
fluorescent imaging and PDT. As shown in Figure 11 (b and c), the tumors in the two control 
groups without UCNs-PpIX nanoparticles kept on growing to a ~2.6-fold volume in 11 days, 
indicating that NIR light alone has no effect on the growth of the tumor tissue. On the 
contrary, NIR irradiation together with injection of Cov6-FA and Cov6-TPP significantly 
inhibited the tumor growth in spite of the irradiation only performed for an hour in the first 2 
days. Especially, Cov6-TPP nanoparticles under NIR irradiation show stronger ability of 
inhibiting tumor growth than that of Cov6-FA during the whole period of in vivo experiment. 
This result clearly suggests that TPP modified nanoparticles near mitochondria exert much 
higher PDT efficacy than FA modified ones near cell membrane.    
 
The histological results from tumor-bearing mouse model were shown in Figure 12. The 
morphology, size and staining of the tumor cells in control groups (whether with or without 
laser irradiation) are at variance, indicating the continuous growth of tumor cells without 
nanoparticles. Meanwhile, after injection of nanoparticles, the tumor still kept growing 
without NIR irradiation. In contrast, markedly increased death of cells was observed after 
irradiation, as obvious blank or unstained areas can be observed. Interestingly, green 
fluorescence emitted from Cov6-TPP groups (with or without laser) 12 days after injection, 
and the illuminating positions overlay the areas of apoptotic/necrotic tumor cells. On the 
contrary, the fluorescence of UCNs cannot be observed for the cell membrane targeted Cov6-
FA sample, which may suggest that the membrane-targeting mode easily results in the 
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metabolism. This result indicated that the nanoparticles with the mitochondria targeting 
behavior could also applicable for both long-term therapy and long-term fluorescent imaging.  
 
3. Discussion 
This work modified a classical synthetic process to coat the outer layer of silica by using 
aminopropyltriethoxysilane (or PpIX conjugated aminopropyltriethoxysilane) as a precursor, 
and the thickness of the coating layer can be restricted in ~3 nm. As we know, the efficiency 
of ROS production is based on the energy transfer between UCNs as a donor and PS 
molecules as an acceptor which is inversely proportional to the sixth power of the distance 
between the donor and acceptor pair[45,46]. Therefore, the thickness of the coating layer outside 
UCNs is significantly related to the ROS generation efficiency. Our results showed that, 
compared to sample TEOS with a coating layer of ~15 nm in thickness, which is comparable 
to the references[9-16], all the samples with a coating layer of ~3 nm in thickness had much 
higher energy transfer efficiency between PpIX and UCNs for enhancing ROS generation 
efficiency. Meanwhile the covalent bond between PpIX and aminopropyltriethoxysilane 
enables the control of the amount of PpIX loading within the thin silica layer, which resulted 
in the controllability of ROS production.  
 
Another advance for current coating protocol is that the -NH2 from 
aminopropyltriethoxysilane presented on the surface provide further surface modification 
capabilities for subcellular localization.  FA is one of the well-established ligands for 
targeting certain types of cancer cell including HeLa cells in current work because folate 
receptors in such cells are significantly upregulated compared to normal healthy cells[37, 40]. In 
this paper, FA-modified UCNs-PpIX nanoparticles are mostly located near the cellular 
membrane instead of lysosome or endosome shown in the literature[37,40]. This is possibly 
owing to the multivalent FA receptor association of FA-modified UCNs-PpIX nanoparticles 
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and HeLa cells to undergo cellular internalization via endocytosis, which is consistent with 
the notion that high binding avidity can slow down the penetration of nanocarriers due to a 
‘binding-site barrier’[47]. Meanwhile, TPP is a lipophilic molecule with a cationic 
phosphonium head, which has been demonstrated for mitochondria-targeting delivery of drug 
payloads. This paper describes for the first time conjugating TPP on the surface of UCNs-
PpIX nanoparticles rending the nanoparticles with the ability to target the mitochondria of 
HeLa cells, which may be attributed to the substantial negative membrane potential at the 
mitochondrial inner membrane[41,42].  
 
Although various approaches to improve ROS generation have been designed, unclear 
mechanism still remains in the effectiveness of ROS generation on PDT treatment. [6-16,30-
34,48,49]   Some studies[14,16,47-50] reported the relationship between the concentration of 
nanoparticles or PS and PDT efficacy, but the concentration of nanoparticles or PS is not 
directly related to the rate or amount of ROS generation. Based on our nanoplatforms, it was 
possible to study whether the amount of ROS generated affects the capability of killing cancer 
cells, which has not been reported before. As shown in Figure 8 and Figure 9, we first 
demonstrated that the dose of ROS does not significantly affect the PDT efficacy, at least in 
the range investigated in this paper. Since it is difficult to quantitate the amount of 
nanoplatforms at each specific site, the relationship between the ROS generation and PDT 
efficacy still needs further investigation based on the quantitative data of local ROS 
generation. 
 
The influence of ROS generating time on PDT efficacy is of great importance, because the 
half-life of 1O2 is as short as 40 ns, during which the amount of ROS generation may not be 
sufficient to damage the tumor cells.  In our experiments, we found that a 10 min NIR 
irradiation leads to a certain decrease of cell viability and a prolonged irradiation to more than 
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30 min results in a further decrease. Our FACS result showed that both mitochondria targeting 
and cell membrane location show a similar cell death mechanism within 15 min irradiation, 
but it shows a position-dependent phenomenon when further irradiated for 60 min. This result 
may be explained by the hypothesis of Nel et. al. [51] on the mechanism of hierarchical 
oxidative stress: the lowest level of oxidative stress is associated with the induction of 
antioxidant and detoxification defense, but at higher levels of oxidative stress, this protective 
response is overtaken by inflammation and death. The results also showed that after extending 
irradiation time to 60 min, direct destroy of cell membrane is the main death mechanism for 
locating nanoparticles on cell membrane, and necrosis or late-stage apoptosis with keeping 
membrane integrity is dominant for targeting nanoparticles to mitochondria, which indicates 
that extending ROS generation time leads to different cell responses changing from 
antioxidant defense to different types of cell death. Contrary to keeping cells integrity, the cell 
rupture can spread throughout the body for a long time[52], and despite of the unclear effect[5], 
the segments may cause reactions in normal tissues leading to inflammation and edema[53].  
 
In vitro and in vivo studies of the effect of the location of nanoplatform on the PDT efficacy 
was first performed in this study. Our results showed that the average cell viabilities under the 
same condition of irradiation for all unmodified UCNs-PpIX nanoparticles (shown in Figure 
6) were at almost the same level. Meanwhile with or without a washing process, the average 
cell viabilities under the same condition of irradiation were also at the same level with a very 
slight decrease. This implies that the ROS generation outside the HeLa cells does not 
obviously affect the photodynamic efficacy. Previous reports[17,54,55] also indicated that neat 
PS outside cells possessed extremely low PDT efficacy despite their capability for high 
photochemical yield of ROS.  Thus, it indicates that ROS localization inside cells is more 
important than outside. Furthermore, our experimental results first indicate that the viability 
of HeLa cells treated with FA-modified UCNs-PpIX nanoparticles had a much higher 
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decrease, ~15%, than those treated with unmodified UCNs-PpIX nanoparticles, and that the 
HeLa cell viability treated by mitochondria-targeting TPP-modified UCNs-PpIX 
nanoparticles decreased to ~40%. Previous researches[54,55] suggested that mitochondrion is 
the more potent site for PDT than other subcellular sites such as lysosome for cytotoxic 
activity to living cells. However, those experiments employed different PSs for different 
locations, so it was difficult to determine the most influential factors of the PDT efficacy: 
subcellular location, concentration and/or some intrinsic properties. This work was designed 
to incorporate one sensitizer PpIX for comparison of the influence of cellular location of the 
nanoplatform on PDT efficacy with a similar amount of cellular uptake, and therefore 
provides direct evidence that the more efficient approach for increasing PDT efficacy is to 
tailor the nanoplatform to target certain subcellular sites such as mitochondria. 
 
4. Conclusion 
 
With the minimization of the external layer thickness and the increase of the loading capacity 
of PpIX outside a UCN core, the ROS generation rate can be adjusted and controllable. 
Meanwhile through modifying their surface by targeting ligands of FA and TPP, the UCNs-
PpIX nanoparticles can target the cell membrane and mitochondria of HeLa cells, respectively. 
Based on these newly designed nanoplatforms, we found that the mitochondria targeting 
mode is more significant for the PDT performance of both cell killing (in vitro) and tumor 
growth inhibition (in vivo) than the cell membrane mode. The HeLa cells incubated with 
UCNs-PpIX nanoparticles showed different death mechanisms after 60 min laser exposure: 
membrane segmentation for membrane targeting, and necrosis or late-stage apoptosis for 
mitochondria targeting. Moreover, the subcellular position near mitochondria is much more 
efficient and effective for higher PDT efficacy than increasing ROS generating amount. In 
summary, we developed novel UCNs-PpIX nanoparticles, which can not only control and 
optimize ROS generation but also target subcellular-scale organelles. The findings provide 
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evidence that specific subcellular targeting strategy may be of more importance for 
optimizing PDT efficacy than elevating the dose of ROS. 
 
 
Supporting Information 
Supporting Information, including experimental section, the UV-Vis absorption for the 
calculation of PpIX loading and ROS generation, fluorescent spectra, luminescence decay 
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modification, and the discussion on ruling out photothermal effect, is available from the 
Wiley Online Library or from the author. 
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Figure 1. Schematic illustration of modified microemulsion approaches for coating silica and 
PS on upconversion nanoparticles. The inset table shows the feeding and loading amounts of 
PpIX molecules for each sample and their energy transfer efficiency calculated from 
fluorescent intensity.  
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Figure 2. (a) The ROS generation of different samples as indicated by the decay of 
absorbance of DPBF at 410 nm, and (b) the 1O2 generation of different samples as indicated 
by the decay of absorbance of ABMDMA 
  
     (a)                                                                    (b) 
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Figure 3. Right Panel: Schematic illustration of UCNs-PpIX nanoparticles surface 
modification with folic acid (FA) and (3-carboxypropyl)triphenylphosphonium bromide 
(TPP), respectively. Two-photon confocal fluorescent microscopic images of HeLa cells 
incubated with different surface modified Cov6 samples. Each series can be classified into the 
nuclei of cells (being dyed in blue by DAPI for visualization), PpIX-loaded upconversion 
nanoparticles, and a combination of both channels, respectively. The light source was a 980 
nm pulse laser. Left panel: Cellular uptake of different surface modified nanoparticles. 
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Figure 4. TEM images of HeLa cells incubated with different surface modified Cov6 
samples, showing different targeting positions: Unmodified, FA modified and TPP modified 
sample Cov6 for untargeted, membrane targeted and near mitochondria location, respectively.  
Arrows point to the aggregation of ROS generation nanoplatforms. 
 
  
25 
 
Figure 5. Multichannel confocal fluorescence micrographs. Blue channel (λex=385 nm, 
λem=470 nm) for DAPI stained nuclei. Red channel (λex=552 nm, λem=660 nm) for PpIX. 
Green channel (λex=488 nm, λem=530 nm) for Rh123 stained mitochondria. 
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Control 
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Figure 6. The viability of HeLa cells incubated with unmodified samples in dark, or under 
980 nm irradiation with/without washing off the UCNs-PpIX nanoparticles outside cells.  
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Figure 7. The viability of HeLa cells incubated with different surface modified Cov6 samples 
after irradiation for various periods of time with a 980 nm NIR laser.  
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Figure 8. Cytotoxicity of cells incubated with FA-modified samples exposing to 0~60 min 
NIR irradiation. 
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Figure 9. The viability of HeLa cells incubated with samples APTS and Cov6 with different 
surface modifications in dark, and under 15 min and 40 min irradiations, respectively. 
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Figure 10. Fluorescein annexin-V-FITC/PI double labeling flow cytometry results for HeLa 
cells incubated with samples Cov6-FA and Cov6-TPP in dark and under 15 min and 60 min 
irradiations, respectively.  
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Figure 11. (a) The photograph of the tumor in a mouse exposed to 980 nm laser, showing the 
upconversion fluorescence of UCNs-PpIX nanoparticles; (b) the evolution of tumor size under 
different treatments, in which the red arrow shows that the laser irradiation was implemented 
on the first and second day for 30 min in each day; (c) The photograph of the tumor size 
evolution from day 0 to day 12. Scale bar is 1 cm. 
     
(a)                                                       (b) 
 
(c) 
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Figure 12. Hematoxylin & Eosin (H&E) stained tumor tissues harvested from the mice with 
different treatments after 12 days. The 3rd and 5th Columns are the fluorescent microscopic 
observation of the corresponding samples of the 2nd and 4th Columns, respectively. 
 
 
 
 
 
